Type 2 Diabetes Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2019-2029
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Accessing in-depth insights from the ‘Type 2 Diabetes’ report will help you:
- Understand the etiology, pathophysiology, symptoms, and prognosis of Type 2 Diabetes to get a better overview of the market.
- Gain an insight into the background of Type 2 Diabetes as well as learn the risk factors and comorbidities involved with the disease.
- Learn the process of disease management and treatment to better deal with Type 2 Diabetes.
- Analyze the current and future players to understand their competitive position within the market.
- Assess the drivers for the global as well as regional Type 2 Diabetes market and learn their impact.
How is the ‘Type 2 Diabetes’ report unique from other reports in the market?
- Develop and design your in-licensing and out-licensing strategies, using a detailed overview of current pipeline products and technologies to identify companies with the most robust pipelines.
- Develop business strategies by understanding the trends shaping and driving the global type 2 diabetes therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global type 2 diabetes market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track drug sales in the global type 2 diabetes therapeutics market from 2019-2029.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
We recommend this valuable source of information to anyone involved in:
- Pharmaceutical/Biotech/Drug Manufacturing Industries (Big Pharma, Small Biotech, Start-ups, etc.),
- Pharmaceutical Industry Suppliers (e.g., Consulting Companies, CMOs, CDMOs, CROs, Technology Vendors)
- Consulting and Professional Services (e.g., Investment Companies, Investment Banks, Equity Companies, etc.)
- Pharma Manufacturers/Distributors (Innovative, Biotech, Generics, Biosimilars, Rare/Orphan Disease)
- Financial Institutions (Investors in Pharma/Biotech, Pricing Consultancies)/Parallel Trade Organizations
- Healthcare Organizations (HTA Bodies, Reimbursement Groups and Payers, Government Healthcare Organizations)
- Clinical Research Organizations (CROs)
To Get a Snapshot of the Type 2 Diabetes Report
Type 2 Diabetes (T2D) Market Report Overview
The T2D market value for the 9 markets (9MM) was $45.9 billion in 2019. T2D is a chronic disease characterized by insulin resistance and pancreatic β-cell failure, as defined by the International Classification of Diseases 11th edition (ICD-11), with an underlying genetic predisposition heavily influenced by diet and lifestyle. This disease is a multi-causal, heterogeneous, and progressive cardiometabolic condition that is commonly associated with obesity, dyslipidemia, hypertension, inflammation, and endothelial dysfunction. The prevalence of diabetes is expected to grow rapidly, as it is associated with aging populations, increasing urbanization, economic development, and the increase in the prevalence of risk factors like obesity, unhealthy dietary habits, and physical inactivity.
The T2D market research report provides an analysis of the key dynamics of the T2D market. The report also offers insights into the key industry drivers and challenges. It also covers deals and R&D strategies in detail to highlight potential business opportunities.
Market Size (2019 in 9MM) | $45.9 billion |
Key Regions | The US, 5EU (France, Germany, Italy, Spain, and the UK), and APAC (China, India, and Japan) |
Leading Players | Takeda, GSK, AstraZeneca, Novo Nordisk, Sanofi, Eli Lilly, Merck, and others |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
T2D Market Drivers
The most important driver of growth in the T2D marketplace will be a dramatic increase in the prevalence and diagnosis of the disease. The rise in T2D-related comorbidities has fueled the more aggressive approach to the treatment and the use of multiple-drug therapies.
The obesity epidemic in the US will fuel the number of T2D patients. The main shift in the position of the ADA guidelines, reflected in a more personalized and patient-tailored approach, will drive the market for many me-too therapies in the T2D space. Diabetes screening programs for high-risk patients could increase the patient pool. Increasing rates of obesity and heart disease lead to a likely increase in the incidence of Type 2 Diabetes, further driven by the ageing population in the EU.
Buy the Full Report to Know More About the Drivers of the T2D Market, Download A Free Report Sample
T2D Market Unmet Needs
Several newly marketed and late-stage pipeline products are positioned to somewhat address the unmet needs in the treatment of T2D. New insulin formulations are also emerging, but they only offer a modest increase in overall efficacy and safety. Overall, the majority of unmet needs in T2D will remain unfulfilled for the foreseeable future. Patients still lack an effective antidiabetic treatment that can be used in all phases of the chronic disease, leaving a significant growth opportunity for new patented products that can meet these needs.
Buy the Full Report to Know More About the Unmet Needs in the T2D Market, Download A Free Report Sample
T2D Market Segmentation by Regions
The key regions in the T2D market are the US, 5EU (France, Germany, Italy, Spain, and the UK), and APAC (China, India, and Japan). The US had the highest share in 2019, followed by APAC, and 5EU respectively.
T2D Market Analysis by Regions, 2019 (%)
Buy the Full Report for More Regional Insights on the T2D Market, Download A Free Report Sample
T2D Market - Competitive Landscape
The leading players in the T2D market are Takeda, GSK, AstraZeneca, Novo Nordisk, Sanofi, Eli Lilly, Merck, and others. Takeda was the leading sponsor of cell therapy trials in T2D market in 2019.
T2D Market Analysis by Companies, 2019 (%)
Buy the Full Report for More Insights On Companies in the T2D Market, Download A Free Report Sample
Key Highlights
The report will help to understand:
- Develop and design your in-licensing and out-licensing strategies, using a detailed overview of current pipeline products and technologies to identify companies with the most robust pipelines.
- Develop business strategies by understanding the trends shaping and driving the global type 2 diabetes therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global type 2 diabetes market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track drug sales in the global type 2 diabetes therapeutics market from 2019-2029.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Reasons to Buy
The report will help to understand:
- Develop and design your in-licensing and out-licensing strategies, using a detailed overview of current pipeline products and technologies to identify companies with the most robust pipelines.
- Develop business strategies by understanding the trends shaping and driving the global type 2 diabetes therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global type 2 diabetes market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track drug sales in the global type 2 diabetes therapeutics market from 2019-2029.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Novo Nordisk
Sanofi
AstraZeneca
Merck & Co.
Boehringer Ingelheim
GlaxoSmithKline
Takeda
Roche
Pfizer
Johnson & Johnson
Novartis
Theracos
Lexicon Pharmaceuticals
Hua Medicine Shanghai Ltd
Tonghua Dongbao Pharmaceutical Co Ltd
Jiangsu Hengrui Medicine Co Ltd.
Sihuan Pharmaceutical Holdings Group
Biocon Ltd
Oramed Pharamceuticals
Table of Contents
Table
Figures
Frequently asked questions
-
What was the T2D market size in the 9MM in 2019?
The T2D market value for the 9MM was $45.9 billion in 2019.Some of the leading players in the T2D market are Takeda, GSK, AstraZeneca, Novo Nordisk, Sanofi, Eli Lilly, Merck, and others.
-
What are the key regions in the T2D market?
The key regions in the T2D market are the US, 5EU (France, Germany, Italy, Spain, and the UK), and APAC (China, India, and Japan).
-
Which region has the highest share in the T2D market?
The US has the highest share in the T2D market.
-
Who are the leading players in the T2D market?
The leading players in the T2D market are Takeda, GSK, AstraZeneca, Novo Nordisk, Sanofi, Eli Lilly, Merck, and others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.